Zhejiang Gongdong Medical Technology Co.,Ltd. (605369.SS)
CNY 29.34
(-0.47%)
CNY 29.34
(-0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 975.08 Million | 1.46 Billion | 1.19 Billion | 829.65 Million | 552.97 Million | 482.55 Million |
| Cost of Revenue | 656.69 Million | 888.56 Million | 664.52 Million | 418.79 Million | 307.37 Million | 285.45 Million |
| Gross Profit | 318.39 Million | 580.12 Million | 529.72 Million | 410.86 Million | 245.6 Million | 197.09 Million |
| Operating Expenses | 193.93 Million | 240.88 Million | 185.22 Million | 134.09 Million | 111.87 Million | 100.91 Million |
| Selling, General and Administrative Expenses | 69.24 Million | 103.53 Million | 79.57 Million | 63.89 Million | 55.98 Million | 52.29 Million |
| Research and Development Expenses | 47.81 Million | 72.34 Million | 58.29 Million | 36.98 Million | 22.33 Million | 18.86 Million |
| Other Expenses | -1.67 Million | 65 Million | 47.36 Million | 33.22 Million | 33.55 Million | 2.57 Million |
| Cost and Expenses | 855.36 Million | 1.12 Billion | 849.75 Million | 552.89 Million | 419.24 Million | 386.36 Million |
| Operating Income | 119.72 Million | 371.83 Million | 359.72 Million | 263.26 Million | 132.4 Million | 95.82 Million |
| Interest Expense | 1.68 Million | 35.95 Thousand | 28.53 Thousand | 187.97 Thousand | 663.86 Thousand | 275.54 Thousand |
| Income Tax Expense | 10.09 Million | 44.61 Million | 49.74 Million | 36.53 Million | 18.36 Million | 13.47 Million |
| Earnings before Tax | 119.22 Million | 370.66 Million | 360.73 Million | 262.41 Million | 131.95 Million | 98.39 Million |
| Net Income | 109.12 Million | 326.04 Million | 310.98 Million | 225.88 Million | 113.58 Million | 84.92 Million |
| Earnings Per Share Basic | 0.69 | 2.91 | 2.78 | 2.02 | 1.01 | 1.01 |
| Earnings Per Share Diluted | 0.69 | 2.91 | 2.78 | 2.02 | 1.01 | 1.01 |
| Weighted Average Shares Outstanding | 157.5 Million | 112.04 Million | 112 Million | 112 Million | 112 Million | 83.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 157.5 Million | 112.04 Million | 112 Million | 112 Million | 112 Million | 83.73 Million |
| Gross Margin | 0.33 | 0.39 | 0.44 | 0.50 | 0.44 | 0.41 |
| EBIT Margin | 0.21 | 0.29 | 0.32 | 0.34 | 0.27 | 0.23 |
| Profit Margin | 0.11 | 0.22 | 0.26 | 0.27 | 0.21 | 0.18 |
| EBITDA | 200.09 Million | 411.93 Million | 382.56 Million | 281.51 Million | 149.02 Million | 111.93 Million |
| Earnings Before Tax Margin | 0.12 | 0.25 | 0.30 | 0.32 | 0.24 | 0.20 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 279.13 Million | 279.88 Million | 271.91 Million | 262.4 Million | 975.08 Million | 254.47 Million |
| Cost of Revenue | 187.39 Million | 190.93 Million | 181.8 Million | 172.93 Million | 656.69 Million | 172.94 Million |
| Gross Profit | 91.73 Million | 88.94 Million | 90.11 Million | 89.46 Million | 318.39 Million | 81.52 Million |
| Operating Expenses | 44.48 Million | 42.19 Million | 47.29 Million | 58.05 Million | 202.29 Million | 53.78 Million |
| Selling, General and Administrative Expenses | 31.39 Million | 30.49 Million | 34.99 Million | -18.68 Million | - | 68.36 Million |
| Research and Development Expenses | 13.09 Million | 11.7 Million | 11.13 Million | 12.34 Million | - | 9.92 Million |
| Other Expenses | - | 81.56 Thousand | -72.83 Thousand | -398.73 Thousand | -495.36 Thousand | -1.18 Million |
| Cost and Expenses | 231.88 Million | 233.12 Million | 229.1 Million | 230.99 Million | 858.98 Million | 226.72 Million |
| Operating Income | 47.24 Million | 46.75 Million | 52.13 Million | 20.87 Million | 119.72 Million | 30.44 Million |
| Interest Expense | 924.31 Thousand | 303.15 Thousand | 448.86 Thousand | - | 1.44 Million | - |
| Income Tax Expense | 4.89 Million | 4.87 Million | 6.95 Million | -402.41 Thousand | 10.09 Million | 3.02 Million |
| Earnings before Tax | 48.83 Million | 58.62 Million | 52.06 Million | 20.47 Million | 119.22 Million | 30.31 Million |
| Net Income | 46.1 Million | 50.18 Million | 45.1 Million | 20.87 Million | 109.12 Million | 27.29 Million |
| Earnings Per Share Basic | 0.29 | 0.32 | 0.40 | 0.18 | - | 0.24 |
| Earnings Per Share Diluted | 0.29 | 0.32 | 0.40 | 0.18 | - | 0.24 |
| Weighted Average Shares Outstanding | 156.32 Million | 157.14 Million | 112.77 Million | 114.87 Million | 112.5 Million | 112.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 156.32 Million | 157.14 Million | 112.77 Million | 114.87 Million | 112.5 Million | 112.23 Million |
| Gross Margin | 0.33 | 0.32 | 0.33 | 0.34 | 0.33 | 0.32 |
| EBIT Margin | 0.18 | 0.25 | 0.20 | 0.15 | - | 0.07 |
| Profit Margin | 0.17 | 0.18 | 0.17 | 0.08 | 0.11 | 0.11 |
| EBITDA | 49.75 Million | 68.93 Million | 53.93 Million | 38.99 Million | - | 17 Million |
| Earnings Before Tax Margin | 0.17 | 0.17 | 0.19 | 0.08 | 0.12 | 0.12 |
IFINSER
603648
300261
CLCS
PIRC
IXRRF